Global Pediatric Gastroenterology Market Size & Trends

Advertisement

Abbott Laboratories, Boston Scientific Corporation, Johnson & Johnson, Medtronic PLC, Nestlé Health Science, Pfizer Inc., Sandoz International GmbH (a Novartis subsidiary), Takeda Pharmaceutical Company Limited, Tillotts Pharma AG, UCB S.A., AbbVie Inc., Allergan plc, AstraZeneca PLC, Mylan N.V., and Merck & Co., Inc. among others, are some of the key players in the global pediatric gastroenterology market.

Brooklyn, New York, June 23, 2023 (GLOBE NEWSWIRE) — According to a new market research report published by Global Market Estimates, the Global Pediatric Gastroenterology Market is projected to grow at a CAGR of 8.2% from 2023 to 2028.

The market for pediatric gastroenterology is expected to grow due to factors such as the rising prevalence of gastrointestinal disorders in children, advancements in diagnostic technologies, and a growing emphasis on early intervention and preventive care. Additionally, the market is being fueled by factors such as increasing healthcare infrastructure and investments, growing demand for specialized care, and heightened awareness and education regarding pediatric gastrointestinal health.

Advertisement

Browse 147 Market Data Tables and 115 Figures spread through 163 Pages and in-depth TOC on “Global Pediatric Gastroenterology Market – Forecast to 2028’’

Key Market Insights

  • As per the condition outlook, the gastroesophageal reflux disease (GERD) segment is expected to be the largest segment in the global pediatric gastroenterology market from 2023 to 2028.
  • As per the service type outlook, the diagnostic services segment is expected to be the largest segment in the global pediatric gastroenterology market from 2023 to 2028.
  • The Asia Pacific region is analyzed to be the fastest-growing segment in the market.
  • North America region will have the largest share in the market during the forecast period of 2023-2028.
  • Abbott Laboratories, Boston Scientific Corporation, Johnson & Johnson, Medtronic PLC, Nestlé Health Science, Pfizer Inc., Sandoz International GmbH (a Novartis subsidiary), Takeda Pharmaceutical Company Limited, Tillotts Pharma AG, UCB S.A., AbbVie Inc., Allergan plc, AstraZeneca PLC, Mylan N.V., and Merck & Co., Inc. among others, are some of the key players in the global pediatric gastroenterology market.

Request for a sample copy of the report @ https://www.globalmarketestimates.com/market-report/pediatric-gastroenterology-market-4037

Condition Outlook (Revenue, USD Billion, 2023-2028)

  • Gastroesophageal Reflux Disease (GERD)
  • Inflammatory Bowel Disease (IBD)
  • Celiac Disease
  • Others

Service Type Outlook (Revenue, USD Billion, 2023-2028)

  • Diagnostic Services
  • Therapeutic Interventions
  • Other Service Types

Service Provider Outlook (Revenue, USD Billion, 2023-2028)

  • Pediatric Hospitals
  • Pediatric Clinics
  • Other Service Providers

By Regional Outlook (Revenue, USD Billion, 2023-2028)

North America        

  • The U.S.
  • Canada
  • Mexico

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Thailand
  • Indonesia
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of APAC

Central & South America

  • Brazil
  • Argentina
  • Chile
  • Rest of CSA

Middle East & Africa

  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of MEA

Contact: Yash Jain

Director – Global Accounts & Strategic Advisory

Email address: [email protected]

Phone Number: +1 6026667238

Website: www.globalmarketestimates.com

CONTACT: Contact: Yash Jain Director - Global Accounts & Strategic Advisory Email address: [email protected] Phone Number: +1 6026667238 Website: www.globalmarketestimates.com

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.